What we speak about

We focus on high-impact, fast moving topics - helping audiences understand

• Current regulatory trends shaping the innovation environment at the FDA
• How to interpret the evolving landscape and what sponsors need to anticipate
• Not just what’s happening—but what companies should be doing to position themselves strategically in response

Past speaking highlights

• Moderator, DIA “Hot Topics” sessions — frequently called upon last-minute to lead urgent and high-level discussions with senior FDA  .  officials, including the Commissioner
• Keynote Speaker for annual meetings of major trade associations
• Advisor to senior leadership teams, providing private briefings on regulatory shifts and emerging opportunities
• Regular presenter for trade associations, investors, policy groups offering insider perspectives on FDA activities and their implications for members
• Career advice for former regulators and job seekers
• MBA and law classes

Who speak to

• Senior leadership and executive teams
• Boards of directors
• Annual conferences and industry panels
• Webinars and virtual roundtables with fellow experts
• Strategy-focused groups, including patient organizations and advocacy coalitions
• Graduate level classes

Speaking formats

We are available:

• Conference keynotes and panel participation
• Executive and board briefings
• Webinars and virtual events
• In class teaching events